Overview

Probiotics and Irritable Bowel Syndrome

Status:
Completed

Trial end date:
2020-02-29

Target enrollment:
0

Participant gender:
All

Summary

This clinical trial was conducted on 90 IBS patients, who fulfill ROME IV criteria and the IBS diagnostic questionnaire (Arabic version licensed by Rome Foundation) in Egyptair hospital outpatient clinic, Cairo, Egypt between May and December 2019. Data of the patient, with suspected IBS during the study period, were reviewed and the patients who fulfilled the inclusion criteria were enrolled into this study. A written consent was obtained from all included patients. The patients who agreed to participate were then randomly assigned into two equal groups and were followed up after 4 weeks from the first visit.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Ain Shams University

Criteria

Inclusion Criteria:

1-Patients should fulfill Rome Foundation IBS-Diagnostic Questionnaire i.e [Recurrent
abdominal pain (on average, at least 1 day/week in the last 3 months) associated with two
or more of the following: (Related to defecation, Associated with a change in frequency of
stool, Associated with a change in form of stool)].

Exclusion Criteria:

1. Any patient with red flags (e.g. weight or appetite loss, iron deficiency anemia,
fever or rectal bleeding),

2. Known inflammatory bowel disease or celiac disease patients,

3. patients above 50 years of age

4. immuno-compromised patients

5. Refusal to participate in the study